Search by Drug Name or NDC

    NDC 70518-2637-00 Bupropion Hydrochloride 150 mg/1 Details

    Bupropion Hydrochloride 150 mg/1

    Bupropion Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 70518-2637
    Product ID 70518-2637_de1c9ed0-d1e9-5205-e053-2a95a90a7b94
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Bupropion Hydrochloride
    Proprietary Name Suffix XL
    Non-Proprietary Name bupropion hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name REMEDYREPACK INC.
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210015
    Listing Certified Through 2023-12-31

    Package

    NDC 70518-2637-00 (70518263700)

    NDC Package Code 70518-2637-0
    Billing NDC 70518263700
    Package 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2637-0)
    Marketing Start Date 2020-03-18
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL c24bf2f6-9a4c-4eab-ae8e-eb3cf45a85ca Details

    Revised: 5/2022